Learn more at LeadIQ.com

Insights

Fast Track Designation DURECT Corporation's lead drug candidate, Larsucosterol, has been granted a Fast Track Designation by the FDA for the potential treatment of alcohol-associated hepatitis (AH). This designation can significantly expedite the regulatory review process, presenting a sales opportunity for the company upon successful approval.

Recent Partnership The recent partnership between DURECT Corporation and Charles River Laboratories International, Inc. for the expansion of ALZET Osmotic Pumps in the U.S. and Canada indicates potential growth opportunities in new markets and increased product reach. Sales representatives can leverage this collaboration to explore more avenues for distribution and sales.

FDA Approval POSIMIR® (bupivacaine solution), a non-opioid analgesic utilizing innovative SABER® platform technology, has been FDA-approved and is exclusively licensed to Innocoll Pharmaceuticals for distribution in the U.S. This approval provides a sales opportunity for DURECT Corporation to drive revenue through commercial sales and further market penetration.

Strategic Hiring DURECT Corporation's strategic hiring of key personnel like Timothy M. Papp as Chief Financial Officer and Louis Pascarella as CEO signifies a focus on strengthening the leadership team. Sales development representatives can capitalize on the new leadership's vision to align sales strategies with corporate objectives for enhanced sales performance.

Market Expansion The launch of POSIMIR® and the AHFIRM Trial of Larsucosterol in alcohol-associated hepatitis reflect DURECT Corporation's strategic initiatives for market expansion. Sales representatives can leverage these developments to explore new customer segments, establish partnerships, and drive sales growth in the pharmaceutical manufacturing industry.

Similar companies to DURECT Corporation

DURECT Corporation Tech Stack

DURECT Corporation uses 8 technology products and services including Google Analytics, Drupal, Font Awesome, and more. Explore DURECT Corporation's tech stack below.

Google Analytics
Analytics
Drupal
Content Management System
Font Awesome
Font Scripts
Typekit
Font Scripts
Google Font API
Font Scripts
jQuery
Javascript Libraries
Underscore.js
Javascript Libraries
Google Tag Manager
Tag Management

Media & News

DURECT Corporation's Email Address Formats

DURECT Corporation uses at least 1 format(s):

DURECT Corporation Email Formats	Example	Percentage
First.Last@durect.com	John.Doe@durect.com	82%
FLast@durect.com	JDoe@durect.com	15%
Last.First@durect.com	Doe.John@durect.com	2%
Last@durect.com	Doe@durect.com	1%

Frequently Asked Questions

What is DURECT Corporation's phone number?

You can contact DURECT Corporation's main corporate office by phone at

+1-408-777-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DURECT Corporation's official website and social media links?

DURECT Corporation's official website is durect.com and has social profiles on LinkedIn.

How much revenue does DURECT Corporation generate?

As of June 2024, DURECT Corporation's annual revenue reached $35M.

What is DURECT Corporation's NAICS code?

DURECT Corporation's NAICS code is 332994 - Small Arms, Ordnance, and Ordnance Accessories Manufacturing.

How many employees does DURECT Corporation have currently?

As of June 2024, DURECT Corporation has approximately 107 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Medical Officer: N. S.Chief Financial Officer: T. P.Chief Patent Counsel: S. H.. Explore DURECT Corporation's employee directory with LeadIQ.

What industry does DURECT Corporation belong to?

DURECT Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does DURECT Corporation use?

DURECT Corporation's tech stack includes Google AnalyticsDrupalFont AwesomeTypekitGoogle Font APIjQueryUnderscore.jsGoogle Tag Manager.

What is DURECT Corporation's email format?

DURECT Corporation's email format typically follows the pattern of . Find more DURECT Corporation email formats with LeadIQ.

How much funding has DURECT Corporation raised to date?

As of June 2024, DURECT Corporation has raised $15M in funding. The last funding round occurred on Jul 20, 2023 for $15M.

When was DURECT Corporation founded?

DURECT Corporation was founded in 1998.

DURECT Corporation

DURECT Corporation

Pharmaceutical Manufacturing51-200 Employees

DURECT is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol, DURECT’s lead drug candidate, binds to and inhibits the activity of DNA methyltransferases (DNMTs), epigenetic enzymes that are elevated and associated with hypermethylation found in alcohol-associated hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which FDA has granted a Fast Track Designation; non-alcoholic steatohepatitis (NASH) is also being explored. In addition, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER® platform technology, is FDA-approved and is exclusively licensed to Innocoll Pharmaceuticals for sale and distribution in the United States.

Company Overview

Phone number: ✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-408-777-****
Website: durect.com
NAICS Code: 332994 - Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Founded: 1998
Employees: 51-200

Media & News

Funding & Financials

$15M
DURECT Corporation has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $15M.
$10M$50M
DURECT Corporation's revenue is in the range of $10M$50M

Funding & Financials

$15M
DURECT Corporation has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $15M.
$10M$50M
DURECT Corporation's revenue is in the range of $10M$50M

Company Leadership

N. S.
Chief Medical Officer
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. P.
Chief Financial Officer
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. H.
Chief Patent Counsel
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. B.
Pres/Ceo
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. L.
Senior Vice President, Business Development, Commercial, Medical Affairs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. M.
Vp Pharmaceutical Development
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. T.
Senior Executive Administrator And Manager Administrative Svcs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. E.
Vp Regulatory Affairs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. G.
Vp, Birmingham Operations
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. J.
Senior Vice President, Operations And Corporate Quality Assurance
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.